噬菌体疗法
细菌
抗生素
细菌病毒
生物
致病菌
菌群(微生物学)
微生物学
生物技术
噬菌体
大肠杆菌
遗传学
基因
作者
Catherine Loc-Carrillo,Stephen T. Abedon
出处
期刊:Bacteriophage
[Informa]
日期:2011-03-01
卷期号:1 (2): 111-114
被引量:793
标识
DOI:10.4161/bact.1.2.14590
摘要
Many publications list advantages and disadvantages associated with phage therapy, which is the use of bacterial viruses to combat populations of nuisance or pathogenic bacteria. The goal of this commentary is to discuss many of those issues in a single location. In terms of "Pros," for example, phages can be bactericidal, can increase in number over the course of treatment, tend to only minimally disrupt normal flora, are equally effective against antibiotic-sensitive and antibiotic-resistant bacteria, often are easily discovered, seem to be capable of disrupting bacterial biofilms, and can have low inherent toxicities. In addition to these assets, we consider aspects of phage therapy that can contribute to its safety, economics, or convenience, but in ways that are perhaps less essential to the phage potential to combat bacteria. For example, autonomous phage transfer between animals during veterinary application could provide convenience or economic advantages by decreasing the need for repeated phage application, but is not necessarily crucial to therapeutic success. We also consider possible disadvantages to phage use as antibacterial agents. These "Cons," however, tend to be relatively minor.
科研通智能强力驱动
Strongly Powered by AbleSci AI